FindMyKOL
Clinical trialNCT00778063TerminatedInterventional

Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients

NCT00778063 is an interventional trial sponsored by Ochsner Health System. As of 18 Nov 2026, it was terminated. It studies Dexmedetomidine and Saline in Otitis Media. The registry lists an enrollment of 40 participants at 1 site in 1 country. The registry lists a start date of 30 Sept 2008 and a primary completion date of 31 Mar 2013.

SponsorOchsner Health System →Enrollment40Otitis Media
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00778063
FieldValue
Registry IDNCT00778063
StatusTerminated
Study typeInterventional trial
Lead sponsorOchsner Health System
Enrollment40
Registered sites1
Countries1
ConditionsOtitis Media
DrugsDexmedetomidine and Saline
Start30 Sept 2008
Primary completion31 Mar 2013
Study completion31 Mar 2013
Last update posted13 Apr 2023

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the use of intranasal dexmedetomidine to reduce the incidence of emergence delirium during general sevoflurane anesthesia in a pediatric population receiving pressure equalization tubes in one or more ear.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Louisiana, United States1 site
  • Ochsner Clinic Foundation

    New Orleans

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisiana: 1 siteLA1MississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT00778063

Each answer restates registry values shown on this page.

What is NCT00778063?

NCT00778063 is an interventional trial sponsored by Ochsner Health System. It studies Dexmedetomidine and Saline in Otitis Media.

Who leads NCT00778063?

The registry names Dominic S Carollo, MD (study director, Ochsner Health System) and Usha Ramadhyani, MD (principal investigator, Ochsner Health System) as overall officials.

Where does NCT00778063 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

Which drugs does NCT00778063 study?

The registered drug and biological interventions are Dexmedetomidine and Saline.

When did NCT00778063 end?

The registry lists a primary completion date of 31 Mar 2013 and a study completion date of 31 Mar 2013. The sponsor last updated the record on 13 Apr 2023.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.